| Dr Michelle M Lipman, MD | |
|
911 N Elm St Ste 115, Hinsdale, IL 60521-3640 | |
| (630) 861-6620 | |
| Not Available |
| Full Name | Dr Michelle M Lipman |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 25 Years |
| Location | 911 N Elm St Ste 115, Hinsdale, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376548289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 036106773 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Bolingbrook Hospital | Bolingbrook, IL | Hospital |
| Adventist Hinsdale Hospital | Hinsdale, IL | Hospital |
| Adventist La Grange Memorial Hospital | La grange, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Health Partners Inc | 0244135762 | 211 |
News Archive
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech, a leading drug research and development outsourcing company with expertise in discovery chemistry and with operations in China and the United States, today announced that they have signed a definitive agreement under which Charles River and WuXi will combine in a cash and stock transaction valued at approximately $1.6 billion.
The majority of advanced cancer patients who experience agitation achieve control after the first dose of an antipsychotic–antiseizure combination is administered, show study results.
Gliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study funded by the National Institutes of Health, researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas-a type of slow-growing glioma-and found tumor regression in 60 percent of the mice treated.
For years, scientists have observed that when male and female mice eat the same high-fat diet, the males gain significantly more weight than the females.
Albert Einstein College of Medicine of Yeshiva University has received a $3 million grant from the Glenn Foundation for Medical Research to establish the Paul F. Glenn Center for the Biology of Human Aging Research. The grant will fund research to translate recent laboratory and animal discoveries into therapies to slow human aging.
› Verified 9 days ago
| Entity Name | Adventist Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033490651 PECOS PAC ID: 0244135762 Enrollment ID: O20040127000064 |
News Archive
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech, a leading drug research and development outsourcing company with expertise in discovery chemistry and with operations in China and the United States, today announced that they have signed a definitive agreement under which Charles River and WuXi will combine in a cash and stock transaction valued at approximately $1.6 billion.
The majority of advanced cancer patients who experience agitation achieve control after the first dose of an antipsychotic–antiseizure combination is administered, show study results.
Gliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study funded by the National Institutes of Health, researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas-a type of slow-growing glioma-and found tumor regression in 60 percent of the mice treated.
For years, scientists have observed that when male and female mice eat the same high-fat diet, the males gain significantly more weight than the females.
Albert Einstein College of Medicine of Yeshiva University has received a $3 million grant from the Glenn Foundation for Medical Research to establish the Paul F. Glenn Center for the Biology of Human Aging Research. The grant will fund research to translate recent laboratory and animal discoveries into therapies to slow human aging.
› Verified 9 days ago
| Entity Name | North Suburban Gastroenterology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114037041 PECOS PAC ID: 5698678639 Enrollment ID: O20040128000814 |
News Archive
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech, a leading drug research and development outsourcing company with expertise in discovery chemistry and with operations in China and the United States, today announced that they have signed a definitive agreement under which Charles River and WuXi will combine in a cash and stock transaction valued at approximately $1.6 billion.
The majority of advanced cancer patients who experience agitation achieve control after the first dose of an antipsychotic–antiseizure combination is administered, show study results.
Gliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study funded by the National Institutes of Health, researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas-a type of slow-growing glioma-and found tumor regression in 60 percent of the mice treated.
For years, scientists have observed that when male and female mice eat the same high-fat diet, the males gain significantly more weight than the females.
Albert Einstein College of Medicine of Yeshiva University has received a $3 million grant from the Glenn Foundation for Medical Research to establish the Paul F. Glenn Center for the Biology of Human Aging Research. The grant will fund research to translate recent laboratory and animal discoveries into therapies to slow human aging.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle M Lipman, MD 396 Remington Blvd Ste 260, Bolingbrook, IL 60440-4312 Ph: (630) 312-2590 | Dr Michelle M Lipman, MD 911 N Elm St Ste 115, Hinsdale, IL 60521-3640 Ph: (630) 861-6620 |
News Archive
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech, a leading drug research and development outsourcing company with expertise in discovery chemistry and with operations in China and the United States, today announced that they have signed a definitive agreement under which Charles River and WuXi will combine in a cash and stock transaction valued at approximately $1.6 billion.
The majority of advanced cancer patients who experience agitation achieve control after the first dose of an antipsychotic–antiseizure combination is administered, show study results.
Gliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study funded by the National Institutes of Health, researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas-a type of slow-growing glioma-and found tumor regression in 60 percent of the mice treated.
For years, scientists have observed that when male and female mice eat the same high-fat diet, the males gain significantly more weight than the females.
Albert Einstein College of Medicine of Yeshiva University has received a $3 million grant from the Glenn Foundation for Medical Research to establish the Paul F. Glenn Center for the Biology of Human Aging Research. The grant will fund research to translate recent laboratory and animal discoveries into therapies to slow human aging.
› Verified 9 days ago
Dr. Elias J Koliopoulos, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 40 S Clay St Ste 210e, Hinsdale, IL 60521 Phone: 630-323-3540 | |
Raymond J Rapacz, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 11 Salt Creek Ln, Hinsdale, IL 60521 Phone: 630-789-3422 Fax: 630-789-9093 | |
Zainab Ali Baig, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 15 Salt Creek Ln, Suite 111, Hinsdale, IL 60521 Phone: 630-371-0133 Fax: 630-371-0138 | |
Dr. Hong Shing Lee, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 201 E Ogden Ave, Ste 26, Hinsdale, IL 60521 Phone: 630-323-2455 Fax: 630-323-2422 | |
Zeeshan Ali, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 908 N Elm St Ste 110, Hinsdale, IL 60521 Phone: 630-986-8770 | |
Paul A Freier, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11 Salt Creek Ln, Hinsdale, IL 60521 Phone: 630-789-3422 Fax: 630-789-9093 | |
Navya Madamala, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 15 Salt Creek Ln, Suite 111, Ipc, Hinsdale, IL 60521 Phone: 630-371-0133 |